That is essential, because the way a protein in the human body folds figures out if a pharmaceutical will be able to bind to that protein and be efficient. To put it simply, we need to know how these proteins fold if we desire a drug to work. Historically, this has been an experimental procedure (jeff brown biotech pick). However now, Alpha, Fold can forecast protein folding with 92. 4% precision. That's going to make it a lot easier to develop drugs that do what they're developed to do. This was a breakthrough nearly nobody saw. However it's going to have extensive ramifications for curing disease. I forecast that Alpha, Fold will be 98% accurate by the end of 2021.
And, naturally, there will be plenty of investment opportunities in this area, too. Shifting subjects It's going to be an excellent year for bitcoin. I'm bullish on it in 2021 (genetic sequencing companies jeff brown). That stated, I still believe bitcoin will continue to be volatile. We're close to all-time highs. I wouldn't be shocked if it drew back possibly significantly before going greater - angel investor. I've been covering bitcoin for a very long time now. One of the very first research reports I ever released was on bitcoin. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
But at the time of that preliminary suggestion, I entitled my report "What's the Big Deal With Bitcoin?" That reveals you where the discussion was at the time. We were mostly educating readers. But that's not the huge concern any longer. Now we're seeing institutional money finally take an interest in bitcoin. Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some little, specific niche business. Mass, Mutual is a trusted 170-year-old institution. So think of that. In five years, we went from educating readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake.
Which's a big factor I'm bullish on it this year. legacy report prediction. Regards, Jeff Brown, Editor, The Bleeding Edge I have a bonus offer prediction 2020 was a record year for IPOs. 552 U.S. business went public the most in more than 20 years. These companies raised a total of $172 billion. That's an all-time high beating the previous yearly record by 43%. I anticipate 2021 will be another record year in IPOs. There are many great personal companies on the edge of hitting the general public markets And I've been dealing with a brand-new method for you to invest even before these business go public.
This chance has been developing over the last couple of years. I can't wait to tell you everything about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Occasion to find out all the details. Go right here to schedule your spot totally free.
Emma Walsh here, managing editor of the Journal. Routine Journal readers understand that tech isn't our usual beat (what is the legacy report predicting). And when it concerns tech investing, we leave it to the specialists. The good news is, we have a number of such experts in our Rolodex. Our associate Jeff Brown will recognize to our long time readers. He is one of the most accomplished tech investing experts we understand (jeff brown genome sequencing). In reality, he had numerous triple-digit returns in his Brownstone Research study portfolios in 2015. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to have a look at the big photo and forecast what's simply around the corner.
That consists of things like 5G networks, biotech, expert system, and far more. These trends are experiencing rapid growth and developing unbelievable chances for financiers. I wish to make certain all our readers are gotten ready for what's next. And with that in mind, let me draw the picture of what I see coming in the next 12 months Our new 5G (fifth-generation) cordless networks are a topic I've been covering for years now. tech stock. But regardless of what many readers might think, this is a trend that's just starting. Although the COVID-19 pandemic interfered with supply chains in 2015, an impressive 250 million 5G-enabled gadgets were still sold.
And all of this eventually led to Apple delaying the release of the 5G-enabled i, Phone 12 by 2 months (self-driving cars). Losing two months of manufacturing and sales really impacts the number of 5G devices are offered in the fiscal year. When you think about all of that, selling 250 million units is exceptional. More notably, the delays caused by the pandemic created a heap of pent-up need. And that need is now going to be pressed into 2021. In truth, I anticipate that more than 500 million 5G devices will be shipped in 2021 - jeff brown prediction for 2021. And that's not my only 5G prediction When I've discussed 5G in the past, I have actually described its three different phases.
In Stage 2, 5G gadgets go on sale. 5G phones and other items begin to reach customers. And in Stage 3, 5G services begin to be used (melania trump). That's when we start to see applications working on 5G networks. Believe of things like massive multiplayer games over a mobile phone. That's not possible with 4G. It will be with 5G. And my second 5G forecast for 2021 is that we will begin Stage Three by this summer season. This begins something of a virtuous cycle: Many people don't truly care about the technology. But they will care if there are interesting applications that can only be accessed with a 5G phone.
That causes more 5G apps being developed. In fact, 5G is going to open a suite of amazing applications: self-driving cars, the Web of Things, robotic surgical treatment, and more. All of these innovations require 5G. The investment opportunities going forward will be huge. Stepping far from 5G, the next essential innovation I predict in 2021 is CRISPR hereditary editing. CRISPR represents "clustered routinely interspaced brief palindromic repeat." It's a mouthful. But it's one of the most amazing developments in biotechnology. At a high level, CRISPR is an innovation that can edit our genetic makeup as if it were software.
The program can crash or not operate correctly. CRISPR uses a comparable idea but with our genetic code. "Typos" in our genome can result in illness. CRISPR can remedy these "typos." For years, CRISPR was mostly a specific niche innovation that wasn't well comprehended. And throughout that time, there were actually only three business operating in this space. But things are altering. CRISPR is no longer simply theoretical. We're seeing actual results. We're treating illness and seeing that this technology just works. And as an outcome, a "2nd crop" of early-stage CRISPR companies is going public and delivering extraordinary returns. This entire industry is successfully a greenfield opportunity.
There's space for many business to exist in this area. jeff brown biotech stock pick for 2020. And there will be more. That's my prediction for CRISPR in 2021. I anticipate that 2 or 3 more genetic editing business will hold their IPOs. Sticking with biotechnology, we are seeing remarkable things occurring at the merging of biotech and expert system (AI). Google's AI subsidiary, Deep, Mind, just announced at the end of 2020 that its latest Alpha, Fold software can accurately predict the folding of a protein based entirely on its amino acid series with 92. 4% precision. That is very important due to the fact that the way a protein in the body folds identifies if a pharmaceutical will have the ability to bind to that protein and work.
Historically, this has actually been an experimental procedure. However now, Alpha, Fold can anticipate protein folding with 92. 4% accuracy. That's going to make it much easier to produce drugs that do what they're developed to do. And here's my next prediction. I anticipate that Alpha, Fold will be 98% accurate by the end of 2021. And we will see not just one but a number of drug treatments produced using this technology. This was among those breakthroughs that practically nobody noticed. However it's going to have profound ramifications for curing illness. And, naturally, there will be plenty of financial investment chances in this area, too.
It's going to be an excellent year for bitcoin. I'm bullish on it in 2021. That stated, I still think bitcoin will continue to be unpredictable. We're close to all-time highs. I wouldn't be amazed if it drew back perhaps significantly before going higher. I've been covering bitcoin for a long period of time now. One of the first research reports I ever published was on bitcoin - jeff brown predictions for 2021. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ roi for any person who followed my recommendation. However at the time of that preliminary suggestion, I entitled my report, "What's the Big Deal With Bitcoin?" That reveals you where the conversation was at the time.
However nobody is asking that question anymore. Now, we're seeing institutional money finally taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, niche business. brownstone research. Mass, Mutual is a 150-year-old institution. So think of that. In five years, we went from educating readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a huge reason why I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have another perk prediction In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown is worth about $27. 5 million and declares the info depends on date since February 2021, however we could not independently validate this claim. Given Jeff Brown's past, he likely has a significant net worth, however we can't hammer down an accurate figure at this minute. Brown is best understood for his sage-like ability to select winning innovation stocks. He spent more than 25 years investigating technology business like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's substantial experience provides him an excellent viewpoint on the market. He's always on the hunt for new chances, and he shares numerous of his best choices in the Near Future Report.
That's high praise, however it's not ridiculously reasoned. Brown has an outstanding reputation as a stock-picker, and he successfully forecasted a few of the greatest financial occasions of the previous twenty years. Although he doesn't appear to release his choices to the public, the service's success is a direct indication of Brown's stock-picking expertise. No one on Wall Street gets it best whenever, however Jeff Brown's precise forecasts have made him legions of dedicated followers. That says a lot about his capability. The Near Future Report is published by Brownstone Research, a popular monetary research publisher. Brownstone Research offers several research study services with a wide variety of expertises - last year.
The company is likewise associated with Bonner & Partners, another well-respected research study publisher - angel investor. On its site, Brownstone says its objective is to provide retail financiers with professional-grade research: "For too long, the very best financial investment research study has not been readily available to specific financiers. It has actually been normally reserved for financial investment banks, hedge funds, private equity, and high-net-worth clients. jeff brown predictions 2021. The objective of Brownstone Research study is to make that kind of proprietary research readily available to any financiers seeking to gain an edge in the marketplaces. The goal is basic to deliver unique and lucrative investment research study found no place else." -Brownstone Research site excerpt from the Jeff Brown is the creator of Brownstone Research, and he also acts as the company's Chief Investment Expert.
With Brown assisting the ship, Brownstone Research is a powerhouse publisher with lots to provide its clients. After decades of stable success at the helm of top-tier companies like Tesla and Area, X, Elon Musk is a family name throughout the majority of America. If you know even a little bit about the marketplace, you know that he has a reputation as a King Midas of sorts. tech stocks. Everything he touches relies on gold! Jeff is well aware of Elon Musk's executive prowess, so he constantly has an eye out for the Silicon Valley rock star's next relocation. This time, Jeff has an early lead on Elon's next big project.
In fact, Brown believes S.A.V. jeff brown genome sequencing. might be "the most significant pattern of the 2020s, and he's not alone. Take a look at these quotes from other well-known S.A.V. bulls: Elon's next big act will be marrying two innovative technologies: expert system and electrical automobiles. Musk hopes the mix will help him establish the very first fully-autonomous, self-driving vehicles ever. It's absolutely nothing except the automobile industry's Holy Grail. As you know, electric automobiles and self-driving car stocks have been huge this year, but the Wall Street machine has actually approved hype without much concrete outcome. Regardless of an extreme boost in competitors over the previous few years, Brown still believes Musk has the best chance of putting everything together.
tech might be the magic string that ties everything together. S.A.V. means Shared Autonomous Car, and it might be the future of transport. Basically, this technology would enable you to lease your automobile as an autonomous, self-driving taxi when you're not utilizing it. You just leave the car and press a button on an app that tells the car to "join the fleet." Next thing you know, you're relaxing on your sofa while your car shuttles ride-sharers around town. Best of all, you get to keep a hefty portion of the profits. It sounds crazy, but it might be closed than you think.